Sanofi teams with Duke, Mass General for data-driven medication adherence project

Sanofi ($SNY) has teamed up with Duke Clinical Research Institute (DCRI) and Massachusetts General Hospital (MGH) for a machine learning-enabled drug adherence research project. The aim is develop tools that can predict when people with Type 2 diabetes may struggle to stick to their treatment regimens, forecasts Sanofi thinks can aid drug development and clinical trial design. DCRI and MGH, through its Center for Assessment Technology and Continuous Health (CATCH), are independently working to tackle the problem with broadly-similar approaches. Both organizations are applying predictive analytics to datasets that pull in information from nontraditional metrics. This approach, which uses machine learning to look for patterns in data including socio-geographic and behavioral factors, is seen as enabling predictions of adherence that can support a risk-based approach to managing patients. Sanofi outlined…


Link to Full Article: Sanofi teams with Duke, Mass General for data-driven medication adherence project